Alma Lasers International
3 products found

Alma Lasers International products

Aesthetic Precision

Alma-Q - Maximum Power Triple Mode

Q-Switched, LP and Quasi-LP Nd:YAG Laser System. ALMA-Q presents the most powerful triple mode Nd:YAG laser treatment solution available, featuring Q-switched, Long Pulsed and Quasi-Long Pulsed modes on a single, dedicated platform. With Double Pulse technology offering up to 2,000mj per pulse, an extraordinarily short pulse width of 7nsec, unique technological innovations including depth control and fractionated delivery and additional options of working with both the Long Pulsed and Quasi-Long Pulsed Nd:YAG 1064nm laser, ALMA-Q is unmatched in its power and versatility for treating a wide range of aesthetic dermal indications.

ARION - High-End Alexandrite Laser Hair Removal Solution

ARION uses the power of the alexandrite laser to provide fast and effective hair removal as well as treatment of superficial pigmented lesions. ARION features a 755nm wavelength- the gold standard for laser hair removal, especially for skin types I-IV, and the wavelength that is most effectively absorbed by the melanin in the widest range of hair shades and textures. 70 watt power and repetition rates of up to 5Hz make ARION one of the fastest and most powerful alexandrite laser systems on the market. The versatile system is also suitable for treating superficial vascular lesions as well as pigmented skin changes.

Alma - Q-switched Ruby Laser Advantage for Pigmented Lesions and Multi-color Tattoos

“The Q-switched Ruby Laser Adv. antage- for Pigmented Lesions and Multi-color Tattoos”. The SINON II Q-switched Ruby laser (QSRL), with an optimal 694nm wavelength and an extraordinarily short pulse width of only 20nsec, is the safest and most precise laser treatment solution available for pigmented lesions and multi-color tattoo removal.  A high pulse repetition rate and easy spot size changes allow for faster treatments and greater penetration depth, while low fluence values ensure minimal side effects while achieving excellent clinical outcomes.